Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 50 | 40 | 37 | 23 | 23 |
| Accounts receivable | -338 | -138 | 182 | -174 | -134 |
| Other Working Capital | -1,139 | 790 | 574 | -1,846 | -6,176 |
| Other Operating Activity | -1,631 | -2,799 | -2,954 | -2,059 | -2,152 |
| Operating Cash Flow | $-3,058 | $-2,107 | $-2,160 | $-4,055 | $-8,438 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -78 | -236 | -102 | -8 | -5 |
| Investing Cash Flow | $-78 | $-236 | $-102 | $-8 | $-5 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -12 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 0 | 0 | 41 | 1,627 | 14,234 |
| Other Financing Activity | 0 | -8 | 382 | 0 | -724 |
| Financing Cash Flow | $-12 | $-8 | $423 | $1,627 | $13,510 |
| Beginning Cash Position | 10,104 | 12,455 | 14,295 | 16,732 | 11,665 |
| End Cash Position | 6,956 | 10,104 | 12,455 | 14,295 | 16,732 |
| Net Cash Flow | $-3,148 | $-2,351 | $-1,840 | $-2,436 | $5,067 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,058 | -2,107 | -2,160 | -4,055 | -8,438 |
| Capital Expenditure | -78 | -236 | -102 | -8 | -5 |
| Free Cash Flow | -3,136 | -2,343 | -2,262 | -4,063 | -8,443 |